Most Recent Articles by C. Andrew Kistler, MD, PharmD, RPh
Nutrition is a critical factor to consider both in the pre- and postoperative period for patients undergoing a Whipple procedure.
Gastrinomas, rare endocrine tumors, can be treated in multiple ways, regardless of whether the tumor is resectable.
A number of studies have attempted to determine whether multiple myeloma is directly linked to autoimmune disease.
New and old biomarkers should be included in clinical trials to help build a database from which oncologists can draw sound clinical recommendations.
If a patient develops any adverse event while on ponatinib, clinicians should perform a risk-benefit analysis before deciding whether to continue treatment.
More Articles by C. Andrew Kistler, MD, PharmD, RPh
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Bladder-sparing Therapy Outcomes Similar to Cystectomy in Bladder Cancer
- Prostate Cancer Risk and Fruit Intake
- In Focus: Atezolizumab for Non-small Cell Lung Cancer
- Q&A With Tanya Wildes, MD: Managing Multiple Myeloma in Older Patients
- PSA Density More Accurate Than PSA for Predicting Prostate Cancer
- Everolimus, Exemestane Safety Profile Same With Prior Chemo in Breast Cancer
- Lung Cancer: Timing May Affect EGFR mutation-related ctDNA Test Results
- Adding Bevacizumab to Chemo May Prolong Survival in Recurrent Ovarian Cancer
- Bayesian Adaptive Randomization: A Q&A With Brian M. Alexander MD, PhD
- Lenalidomide Prolongs PFS Among Elderly Patients With DLBCL